Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 11.55 CAD -0.86%
Market Cap: 133.9m CAD
Have any thoughts about
Biosyent Inc?
Write Note

Biosyent Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biosyent Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Biosyent Inc
XTSX:RX
Additional Paid In Capital
CA$2.2m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
24%
Bausch Health Companies Inc
TSX:BHC
Additional Paid In Capital
$201m
CAGR 3-Years
-23%
CAGR 5-Years
-13%
CAGR 10-Years
-2%
Sundial Growers Inc
NASDAQ:SNDL
Additional Paid In Capital
CA$73m
CAGR 3-Years
7%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Additional Paid In Capital
$51.5m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Additional Paid In Capital
$625.5m
CAGR 3-Years
214%
CAGR 5-Years
279%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Biosyent Inc
Glance View

Market Cap
133.9m CAD
Industry
Pharmaceuticals

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. BioSyent, through its wholly owned subsidiaries BioSyent Pharma Inc. (BioSyent Pharma) and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary of BioSyent, operates in the non-chemical insecticide business. BioSyent products include Combogesic, Aguettant System, Cathejell, Cysview, FeraMAX 150, FeraMAX Powder, Proktis-M, RepaGyn, and TIBELLA. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Aguettant System are used for a variety of injectable medications in hospitals and the acute care setting. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. RepaGyn for the healing of the vaginal mucosa and the treatment of vaginal dryness.

RX Intrinsic Value
9.83 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Biosyent Inc's Additional Paid In Capital?
Additional Paid In Capital
2.2m CAD

Based on the financial report for Sep 30, 2024, Biosyent Inc's Additional Paid In Capital amounts to 2.2m CAD.

What is Biosyent Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
24%

Over the last year, the Additional Paid In Capital growth was -4%. The average annual Additional Paid In Capital growth rates for Biosyent Inc have been 7% over the past three years , 13% over the past five years , and 24% over the past ten years .

Back to Top